Pacific Biosciences Of California (PACB) Interest Coverage Ratio Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.92% |
| Mar 31, 2025 | -15.05% |
| Dec 31, 2024 | -16.00% |
| Sep 30, 2024 | 15.62% |
| Jun 30, 2024 | -5.57% |
| Mar 31, 2024 | 13.94% |
| Dec 31, 2023 | 12.85% |
| Sep 30, 2023 | 10.51% |
| Jun 30, 2023 | 10.75% |
| Mar 31, 2023 | 9.42% |
| Dec 31, 2022 | 6.21% |
| Sep 30, 2022 | 9.78% |
| Jun 30, 2022 | 8.96% |
| Mar 31, 2022 | 5.49% |
| Dec 31, 2021 | 2.69% |
| Jun 30, 2021 | 14.36% |
| Mar 31, 2021 | 4.59% |
| Mar 31, 2020 | -34.60% |
| Dec 31, 2019 | -1.38% |
| Sep 30, 2019 | -29.22% |
| Jun 30, 2019 | -7.71% |
| Mar 31, 2019 | -12.63% |
| Dec 31, 2018 | -14.72% |
| Sep 30, 2018 | -6.63% |
| Jun 30, 2018 | -4.12% |
| Mar 31, 2018 | 3.15% |
| Dec 31, 2017 | 36.70% |
| Sep 30, 2017 | 36.58% |
| Jun 30, 2017 | 38.18% |